Altimmune Inc — Cash Flow (NASDAQ:ALT) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -34.44 M-78.24 M-62.59 M-75.81 M-79.85 M-67.53 M -67.53 M Cash from investing activities -72.09 M87.52 M-73.4 M13.73 M-28.39 M-132.47 M -132.47 M Cash from financing activities 213.49 M65.1 M56.78 M86.11 M10.04 M206.84 M 206.84 M Free cash flow -34.78 M-90.55 M-62.71 M-75.86 M-79.85 M-67.55 M -67.54 M

Haberler

Altimmune yöneticisi Gill 31 bin dolarlık hisse aldı

Jefferies, Altimmune hissesi için Al tavsiyesini yineledi

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

Altimmune Stock: Neutral Outlook With Big 2026 Catalysts

ALT Pemvidutide Explained: What Makes It Different in MASH

Truist, Altimmune hissesi için alım önerisiyle kapsama başladı

H.C. Wainwright, Altimmune hissesi için hedef fiyatı yükseltti

H.C. Wainwright raises Altimmune stock price target on MASH focus

Altimmune Barclays Konferansı’nda Pemvidutide’in Potansiyelini Anlattı

Altimmune at Barclays Conference: Advancing Pemvidutide’s Potential

Altimmune Leerink Konferansı’nda: MASH Tedavisinde Stratejik İlerlemeler

Altimmune at Leerink Conference: Strategic Advances in MASH Treatment